tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RXRX Stock Latest News

Cathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals
The FlyCathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals
15d ago
RXRX
Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals
16d ago
RXRX
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
PremiumThe Fly
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
16d ago
H
T
Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies
PremiumThe Fly
Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies
16d ago
RXRX
Recursion Pharmaceuticals Proposes Strategic Exscientia Merger
PremiumCompany Announcements
Recursion Pharmaceuticals Proposes Strategic Exscientia Merger
17d ago
8K
RXRX
Recursion: Phase 2 Data of REC-994 for CCM met primary endpoint for safety
PremiumThe FlyRecursion: Phase 2 Data of REC-994 for CCM met primary endpoint for safety
17d ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
22d ago
RXRX
Cathie Wood’s ARK Investment bought 457K shares of Recursion Pharmaceuticals
Premium
The Fly
Cathie Wood’s ARK Investment bought 457K shares of Recursion Pharmaceuticals
1M ago
RXRX
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
PremiumMarket News
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
1M ago
MRK
SNY
Cathie Wood’s ARK Investment bought 156K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 156K shares of Recursion Pharmaceuticals
1M ago
RXRX
Cathie Wood’s ARK Investment bought 139K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 139K shares of Recursion Pharmaceuticals
1M ago
RXRX
CORRECTION – Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
PremiumPress Releases
CORRECTION – Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
1M ago
RXRX
Recursion Pharmaceuticals Enhances Portfolio with Exscientia Acquisition
PremiumCompany AnnouncementsRecursion Pharmaceuticals Enhances Portfolio with Exscientia Acquisition
1M ago
8K
RXRX
Recursion Pharmaceuticals reports Q2 EPS (40c), consensus (40c)
Premium
The Fly
Recursion Pharmaceuticals reports Q2 EPS (40c), consensus (40c)
1M ago
RXRX
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
Premium
Press Releases
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
1M ago
RXRX
Recursion Pharmaceuticals to combine with Exscientia in all-stock deal
PremiumThe Fly
Recursion Pharmaceuticals to combine with Exscientia in all-stock deal
1M ago
EXAI
RXRX
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
PremiumPress Releases
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
1M ago
RXRX
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
PremiumPress Releases
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
1M ago
RXRX
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
PremiumPress Releases
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
2M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe FlyRecursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion Pharmaceuticals put volume heavy and directionally bearish
Premium
The Fly
Recursion Pharmaceuticals put volume heavy and directionally bearish
2M ago
RXRX
Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
Premium
The Fly
Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
2M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >